Article
28 Aug 2025
Bill Seeks To Restrict 30-Month Stay In Hatch-Waxman Litigation To One Patent
RANKINGS
This author falls within the Top 20% for their listed topics and industry categories. Based on Mondaq users readership, this author is ranked as VERY POPULAR in United States
AUTHORS CONTENT
Article
03 Jul 2025
U.S. Supreme Court Invites Solicitor General To Submit Briefing On "Skinny Labels"
Article
27 Jun 2025
USPTO Acting Director Denies IPR Institution Based On "Settled Expectations"
Article
09 Jul 2024
Federal Circuit Revives Induced Infringement Claims Despite "Skinny Label" Carve-Out
Article
08 May 2024
FTC Weighs In On Orange Book Listing Of Drug-Device Patents
Article
12 Oct 2022
USPTO Seeks Public Input On Improving Patent "Robustness And Reliability"
Article
18 Feb 2022
Tillis Urges FDA, USPTO To Investigate Potential False Narrative By Drug Critics
Article
25 Jan 2022
Inducement Suit Proceeds Against Insurance Company For Encouraging Use Of Generic Drug
Article
29 Oct 2021
Executive Order On Promoting Competition In The American Economy: A Focus On Patent And Drug Law To Reduce Health Care Spending
Article
24 Sep 2021
Federal Circuit Vacates Judgment, Reinstates Jury's Verdict Of Induced Infringement
Article
04 May 2021
FTC Notches Win In Fifth Circuit Reverse Payment Patent Settlement Case
Article
14 Apr 2016
美国联邦巡回法院支持在美国药品价格竞争与专利期补偿法案（Hatch-Waxman Act）
Article
31 Mar 2016
Federal Circuit Upholds Broad Hatch-Waxman Venue Options For Innovator Pharmaceutical Companies
Article
18 Aug 2015
Federal Circuit's Unanimous En Banc Decision Focuses On "Attribution To A Single Entity" To Establish Divided-Infringement Liability
Article
12 Jun 2015
Federal Circuit Says That Receiving Expert Testimony, Without More, Does Not Trigger Deferential Review Of Claim Construction